Ads
related to: fanapt vs risperdal cost chart- 109 S High St #100, Columbus, OH · Directions · (614) 224-4261
Search results
Results From The WOW.Com Content Network
Iloperidone is indicated for the treatment of schizophrenia and mania or mixed episodes in bipolar I disorder. [2] [3] In a 2013 study in a comparison of 15 antipsychotic drugs in effectivity in treating schizophrenic symptoms, iloperidone demonstrated mild effectiveness — as effective as lurasidone, and 13 to 15% less effective than ziprasidone, chlorpromazine, and asenapine. [4]
Johnson & Johnson gave more than $700,000 to a research center that was headed by Biederman from 2002 to 2005, where research was conducted, in part, on Risperdal, the company's antipsychotic drug. Biederman has responded saying that the money did not influence him and that he did not promote a specific diagnosis or treatment.
Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic [2] used to treat schizophrenia and bipolar disorder, [2] as well as aggressive and self-injurious behaviors associated with autism spectrum disorder. [9]
If 25% of old neuroleptic use switches to Risperdal, being on average 4 times IIlOilO expensive, an achievable objective, the market grows with 75% which is about the growth 93-2000 needed ro feed the Risperdal forecast. The 6.6% annual growth allows ro reach the 298 min US$ Risperdal sales in 2000.
They were well-versed in Risperdal’s rumored dangers, because those dangers had been part of their old sales pitches. They had harped on the point that patients who took Risperdal gained large amounts of weight and even ended up with diabetes. Before long, Sheller had a few prospective clients with possible diabetes claims against Risperdal.
Another goal for the coming year was to “maximize and grow Risperdal’s market leadership in geriatrics and long term care.” Risperdal was already well ahead of Zyprexa in dementia market share, with 50 percent of the entire market. The goal was to boost that share still higher, to 57 percent, with sales of $302 million.